Are current scales adequate for assessing quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? [PDF]
Demirli Atici S, Canda AE, Terzi MC.
europepmc +1 more source
Hyperthermic intraperitoneal chemotherapy enhances survival outcomes in primary ovarian cancer following cytoreductive surgery: a systematic review and meta-analysis. [PDF]
Sun Q +6 more
europepmc +1 more source
A case report of cytoreductive surgery of metastatic adrenal cancer in a patient with tumor progression. [PDF]
Chaika O +3 more
europepmc +1 more source
Prospective evidence discourages secondary cytoreductive surgery [PDF]
openaire +2 more sources
Splenectomy in Ovarian Cancer Cytoreductive Surgery: Pre-operative Prediction of Disease, Peri-operative Outcomes and Post-operative Adherence to Antimicrobial Prophylaxis and Immunisation. [PDF]
Corha A +5 more
europepmc +1 more source
Risk factors for early versus late venous thromboembolism after cytoreductive surgery and HIPEC [PDF]
Sohini Khan +4 more
openalex +1 more source
Intensive care scores predict outcomes in patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]
Wimmer J +10 more
europepmc +1 more source
Analysis of Risk Factors for Urinary Tract Infection in Ovarian Cancer Patients After Cytoreductive Surgery and Construction of a Nomogram Model. [PDF]
He M, Li J, Huang L, Liang F.
europepmc +1 more source

